This bill amends the Public Health Service Act to enhance the requirements for State plans concerning Substance Use Prevention, Treatment, and Recovery Services block grants . It mandates that states provide more detailed information regarding their medication-assisted treatment (MAT) programs. Specifically, State plans must now describe the types of drugs available for MAT , as well as their programs and protocols for preventing diversion and misuse of these medications. States will also be required to report data on any misuse of MAT drugs , including instances where they are mixed with other prescription drugs. Furthermore, the bill necessitates reporting on the State's drug screening protocols within its care system, with a particular focus on patients receiving MAT, to ensure comprehensive oversight and accountability.